93 related articles for article (PubMed ID: 20673727)
1. Synthesis, biological evaluation, and structure-activity relationship study of novel cytotoxic aza-caffeic acid derivatives.
Zou H; Wu H; Zhang X; Zhao Y; Stöckigt J; Lou Y; Yu Y
Bioorg Med Chem; 2010 Sep; 18(17):6351-9. PubMed ID: 20673727
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative, antiandrogenic and cytotoxic effects of novel caffeic acid derivatives in LNCaP human androgen-dependent prostate cancer cells.
Sanderson JT; Clabault H; Patton C; Lassalle-Claux G; Jean-François J; Paré AF; Hébert MJ; Surette ME; Touaibia M
Bioorg Med Chem; 2013 Nov; 21(22):7182-93. PubMed ID: 24080105
[TBL] [Abstract][Full Text] [Related]
3. Caffeic acid phenethyl ester induces growth arrest and apoptosis of colon cancer cells via the beta-catenin/T-cell factor signaling.
Xiang D; Wang D; He Y; Xie J; Zhong Z; Li Z; Xie J
Anticancer Drugs; 2006 Aug; 17(7):753-62. PubMed ID: 16926625
[TBL] [Abstract][Full Text] [Related]
4. Cytoprotective effect of caffeic acid phenethyl ester (CAPE) and catechol ring-fluorinated CAPE derivatives against menadione-induced oxidative stress in human endothelial cells.
Wang X; Stavchansky S; Bowman PD; Kerwin SM
Bioorg Med Chem; 2006 Jul; 14(14):4879-87. PubMed ID: 16580214
[TBL] [Abstract][Full Text] [Related]
5. The synthesis and biological evaluation of some caffeic acid amide derivatives: E-2-cyano-(3-substituted phenyl)acrylamides.
Zhou W; Li HB; Xia CN; Zheng XM; Hu WX
Bioorg Med Chem Lett; 2009 Apr; 19(7):1861-5. PubMed ID: 19272773
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic effect of caffeic acid phenethyl ester and its ester and amide analogues in human cervical cancer ME180 cells.
Hung MW; Shiao MS; Tsai LC; Chang GG; Chang TC
Anticancer Res; 2003; 23(6C):4773-80. PubMed ID: 14981925
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of a series of caffeic acid phenethyl amide (CAPA) fluorinated derivatives: comparison of cytoprotective effects to caffeic acid phenethyl ester (CAPE).
Yang J; Marriner GA; Wang X; Bowman PD; Kerwin SM; Stavchansky S
Bioorg Med Chem; 2010 Jul; 18(14):5032-8. PubMed ID: 20598894
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of NF-kappaB inhibitors Bay 11-7085 and caffeic acid phenethyl ester to Ramos and other human B-lymphoma cell lines.
Berger N; Ben Bassat H; Klein BY; Laskov R
Exp Hematol; 2007 Oct; 35(10):1495-509. PubMed ID: 17889719
[TBL] [Abstract][Full Text] [Related]
9. Lipophilic caffeic and ferulic acid derivatives presenting cytotoxicity against human breast cancer cells.
Serafim TL; Carvalho FS; Marques MP; Calheiros R; Silva T; Garrido J; Milhazes N; Borges F; Roleira F; Silva ET; Holy J; Oliveira PJ
Chem Res Toxicol; 2011 May; 24(5):763-74. PubMed ID: 21504213
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of caffeic acid phenethyl ester derivatives, and their cytoprotective and neuritogenic activities in PC12 cells.
Shi H; Xie D; Yang R; Cheng Y
J Agric Food Chem; 2014 Jun; 62(22):5046-53. PubMed ID: 24840770
[TBL] [Abstract][Full Text] [Related]
11. Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer.
Li W; Li N; Tang Y; Li B; Liu L; Zhang X; Fu H; Duan JA
Bioorg Med Chem Lett; 2012 Oct; 22(19):6085-8. PubMed ID: 22954735
[TBL] [Abstract][Full Text] [Related]
12. Caffeoylglycolic and caffeoylamino acid derivatives, halfmers of L-chicoric acid, as new HIV-1 integrase inhibitors.
Lee SU; Shin CG; Lee CK; Lee YS
Eur J Med Chem; 2007 Oct; 42(10):1309-15. PubMed ID: 17434650
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, cytotoxicity, and QSAR study of new aza-cyclopenta[b]fluorene-1,9-dione derivatives.
Miri R; Firuzi O; Peymani P; Zamani M; Mehdipour AR; Heydari Z; Farahani MM; Shafiee A
Chem Biol Drug Des; 2012 Jan; 79(1):68-75. PubMed ID: 21838761
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, structure and structure-activity relationship analysis of caffeic acid amides as potential antimicrobials.
Fu J; Cheng K; Zhang ZM; Fang RQ; Zhu HL
Eur J Med Chem; 2010 Jun; 45(6):2638-43. PubMed ID: 20181415
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, anti-HIV and anti-oxidant activities of caffeoyl 5,6-anhydroquinic acid derivatives.
Ma CM; Kawahata T; Hattori M; Otake T; Wang L; Daneshtalab M
Bioorg Med Chem; 2010 Jan; 18(2):863-9. PubMed ID: 20004585
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in-vitro cytotoxicity evaluation of novel naphtindolizinedione derivatives, part II: improved activity for aza-analogues.
Defant A; Guella G; Mancini I
Arch Pharm (Weinheim); 2009 Feb; 342(2):80-6. PubMed ID: 19173337
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a novel and potent collagen antagonist, caffeic acid phenethyl ester, in human platelets: in vitro and in vivo studies.
Hsiao G; Lee JJ; Lin KH; Shen CH; Fong TH; Chou DS; Sheu JR
Cardiovasc Res; 2007 Sep; 75(4):782-92. PubMed ID: 17560560
[TBL] [Abstract][Full Text] [Related]
18. Caffeic acid phenethyl ester-mediated Nrf2 activation and IkappaB kinase inhibition are involved in NFkappaB inhibitory effect: structural analysis for NFkappaB inhibition.
Lee Y; Shin DH; Kim JH; Hong S; Choi D; Kim YJ; Kwak MK; Jung Y
Eur J Pharmacol; 2010 Sep; 643(1):21-8. PubMed ID: 20599928
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and evaluation of caffeic acid phenethyl ester-based inhibitors targeting a selectivity pocket in the active site of human aldo-keto reductase 1B10.
Soda M; Hu D; Endo S; Takemura M; Li J; Wada R; Ifuku S; Zhao HT; El-Kabbani O; Ohta S; Yamamura K; Toyooka N; Hara A; Matsunaga T
Eur J Med Chem; 2012 Feb; 48():321-9. PubMed ID: 22236472
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel nitrogen-containing polyhydroxylated aromatics as HIV-1 integrase inhibitors from caffeic acid phenethyl ester.
Wang P; Liu C; Sanches T; Zhong Y; Liu B; Xiong J; Neamati N; Zhao G
Bioorg Med Chem Lett; 2009 Aug; 19(16):4574-8. PubMed ID: 19625188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
